Tumor immune-gene expression profiles and peripheral immune phenotypes associated with clinical outcomes of locally advanced pancreatic cancer following FOLFIRINOX.

ESMO Open · 2022 · PMC9271485 · PMID 35576696

Europe PMC DOI

hedged sentence

0.1230

closest p · 2.5× alpha

0.1230

boldest claim

The sentences

showed a trendP = 0.123not close (p > 0.1)

Higher CD14+CD11c+HLA-DR+ monocyte level was significantly associated with poor OS (HR 1.06, 95% CI 1.00-1.13, P = 0.043) while Foxp3+CD4+ regulatory T-cell level showed a trend towards better PFS (HR 0.89, 95% CI 0.77-1.03, P = 0.123).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.